← Eichor
Condition: Ulcerative Colitis In Remission Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ulcerative Colitis In Remission

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Phase N/A · 38 location(s) · Pfizer · NCT06294925
Combination of Diet and Oral Budesonide for Ulcerative Colitis
NA · 6 location(s) · Wolfson Medical Center · NCT05791487
Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopea
Phase N/A · 1 location(s) · Imelda GI Clinical Research Center · NCT07621783
Association Between LRG and Histologic Remission in Ulcerative Colitis
Phase N/A · 1 location(s) · Showa Inan General Hospital · NCT06372613
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
NA · 1 location(s) · University of Chicago · NCT06693310
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagno
NA · 6 location(s) · All India Institute of Medical Sciences · NCT06895252
Effect of Procyanidins in Leaky Gut Repairing in IBD
NA · 1 location(s) · University of Padova · NCT06576700
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NA · 1 location(s) · Central Hospital, Nancy, France · NCT05733845
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Phase 4 · 49 location(s) · Takeda · NCT06095128
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
NA · 22 location(s) · University of California, San Diego · NCT05230173
Critical State of "Remission-Recurrence" of Ulcerative Colitis
Phase N/A · 1 location(s) · Beijing Hospital of Traditional Chinese Medicine · NCT06694883
Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients
NA · 1 location(s) · University of Padova · NCT06642883
LFMT vs Placebo in New Biologic Start for Ulcerative Colitis
Phase 2 · 1 location(s) · University of Alberta · NCT05327790
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Phase 4 · 15 location(s) · Belgian Inflammatory Bowel Disease Research and Development · NCT06113913
Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
NA · 1 location(s) · KU Leuven · NCT02421705
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.